BRPI0907165A2 - R-2-(4-ciclopropanossulfonil-fenil)-n-pirazin-2-il-3-(t etra-hidropiran-4-il)-propionamida cristalina - Google Patents

R-2-(4-ciclopropanossulfonil-fenil)-n-pirazin-2-il-3-(t etra-hidropiran-4-il)-propionamida cristalina

Info

Publication number
BRPI0907165A2
BRPI0907165A2 BRPI0907165-2A BRPI0907165A BRPI0907165A2 BR PI0907165 A2 BRPI0907165 A2 BR PI0907165A2 BR PI0907165 A BRPI0907165 A BR PI0907165A BR PI0907165 A2 BRPI0907165 A2 BR PI0907165A2
Authority
BR
Brazil
Prior art keywords
cyclopropanesulfonyl
pyrazin
propionamide
tetrahydropyran
phenyl
Prior art date
Application number
BRPI0907165-2A
Other languages
English (en)
Inventor
Jeanette Tower Dunlap
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40451065&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0907165(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BRPI0907165A2 publication Critical patent/BRPI0907165A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0907165-2A 2008-01-15 2009-01-07 R-2-(4-ciclopropanossulfonil-fenil)-n-pirazin-2-il-3-(t etra-hidropiran-4-il)-propionamida cristalina BRPI0907165A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2113308P 2008-01-15 2008-01-15
PCT/US2009/030241 WO2009091634A1 (en) 2008-01-15 2009-01-07 Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide

Publications (1)

Publication Number Publication Date
BRPI0907165A2 true BRPI0907165A2 (pt) 2015-07-14

Family

ID=40451065

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907165-2A BRPI0907165A2 (pt) 2008-01-15 2009-01-07 R-2-(4-ciclopropanossulfonil-fenil)-n-pirazin-2-il-3-(t etra-hidropiran-4-il)-propionamida cristalina

Country Status (22)

Country Link
US (1) US20090181981A1 (pt)
EP (1) EP2265271A1 (pt)
JP (1) JP2011509934A (pt)
KR (1) KR20100092061A (pt)
CN (1) CN101909629A (pt)
AR (1) AR070107A1 (pt)
AU (1) AU2009205606A1 (pt)
BR (1) BRPI0907165A2 (pt)
CA (1) CA2712245A1 (pt)
CL (1) CL2009000004A1 (pt)
CO (1) CO6280489A2 (pt)
DO (1) DOP2010000216A (pt)
EA (1) EA201070853A1 (pt)
EC (1) ECSP10010347A (pt)
IL (1) IL206102A0 (pt)
MA (1) MA31985B1 (pt)
MX (1) MX2010007784A (pt)
PE (1) PE20091313A1 (pt)
TN (1) TN2010000299A1 (pt)
TW (1) TW200934772A (pt)
WO (1) WO2009091634A1 (pt)
ZA (1) ZA201003909B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2195293T3 (da) 2007-08-22 2014-02-03 Astrazeneca Ab Cyclopropylamidderivater
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
US20110201622A1 (en) * 2010-02-18 2011-08-18 Collins Craig D Solid Forms Comprising A Cyclopropyl Amide Derivative
BR112012020629A2 (pt) 2010-02-18 2018-06-19 Astrazeneca Ab forma cristalina, e, método para a terapia de um distúrbio
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
KR101220371B1 (ko) 2010-09-17 2013-01-09 현대자동차주식회사 베인펌프
EP2674517B1 (en) * 2011-02-08 2018-10-03 Japan Agency for Marine-Earth Science and Technology Method for producing calcite single crystal
JP2013014534A (ja) * 2011-07-04 2013-01-24 Daicel Corp ベンゾイルギ酸化合物、及びその製造方法
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046768A (en) * 1976-06-17 1977-09-06 Velsicol Chemical Corporation 1-Thiazolyl-5-pyridylcarbonyloxyimidazolidinones
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
US6353111B1 (en) * 1999-12-15 2002-03-05 Hoffmann-La Roche Inc. Trans olefinic glucokinase activators
MXPA02010745A (es) * 2000-05-03 2003-03-10 Hoffmann La Roche Activadores de glucocinasa heteroaromaticos de alquinil-fenilo.
DK1282611T3 (da) * 2000-05-08 2005-02-14 Hoffmann La Roche Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
US6489485B2 (en) * 2000-05-08 2002-12-03 Hoffmann-La Roche Inc. Para-amine substituted phenylamide glucokinase activators
DE60111534T2 (de) * 2000-07-20 2006-05-11 F. Hoffmann-La Roche Ag Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
US6369232B1 (en) * 2000-08-15 2002-04-09 Hoffmann-La Roche Inc. Tetrazolyl-phenyl acetamide glucokinase activators
US6433188B1 (en) * 2000-12-06 2002-08-13 Wendy Lea Corbett Fused heteroaromatic glucokinase activators
DE60117059T2 (de) * 2000-12-06 2006-10-26 F. Hoffmann-La Roche Ag Kondensierte heteroaromatische glucokinaseaktivatoren
US6482951B2 (en) * 2000-12-13 2002-11-19 Hoffmann-La Roche Inc. Isoindolin-1-one glucokinase activators
US6911545B2 (en) * 2001-12-19 2005-06-28 Hoffman-La Roche Inc. Crystals of glucokinase and methods of growing them
US7262196B2 (en) * 2003-02-11 2007-08-28 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
MXPA06012008A (es) * 2004-04-21 2007-01-25 Prosidion Ltd Compuestos de amida tri(ciclo) sustituidos.
KR100890695B1 (ko) * 2004-08-12 2009-03-26 프로시디온 리미티드 치환된 페닐아세트아미드 및 글루코키나제 활성화제로서의그의 용도
GB0418058D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Fluorination process
GB0418046D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Eantioselective process
WO2007051845A1 (en) * 2005-11-03 2007-05-10 Prosidion Ltd Tricyclo substituted amides
US20080293741A1 (en) * 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
WO2007051846A1 (en) * 2005-11-03 2007-05-10 Prosidion Ltd Tricyclo substituted amides

Also Published As

Publication number Publication date
CA2712245A1 (en) 2009-07-23
KR20100092061A (ko) 2010-08-19
AR070107A1 (es) 2010-03-17
AU2009205606A1 (en) 2009-07-23
MX2010007784A (es) 2010-08-09
CN101909629A (zh) 2010-12-08
JP2011509934A (ja) 2011-03-31
EP2265271A1 (en) 2010-12-29
ZA201003909B (en) 2011-11-30
EA201070853A1 (ru) 2010-12-30
WO2009091634A1 (en) 2009-07-23
CO6280489A2 (es) 2011-05-20
US20090181981A1 (en) 2009-07-16
MA31985B1 (fr) 2011-01-03
TW200934772A (en) 2009-08-16
DOP2010000216A (es) 2010-10-15
ECSP10010347A (es) 2010-09-30
IL206102A0 (en) 2010-11-30
CL2009000004A1 (es) 2010-02-19
PE20091313A1 (es) 2009-09-03
TN2010000299A1 (en) 2011-11-11

Similar Documents

Publication Publication Date Title
BRPI0907165A2 (pt) R-2-(4-ciclopropanossulfonil-fenil)-n-pirazin-2-il-3-(t etra-hidropiran-4-il)-propionamida cristalina
DK2340021T3 (da) Substituerede pyrrolidin-2-carboxamider
DK2061766T3 (da) Nye forbindelser
EP2436067A4 (en) AQUEOUS COMPOSITION OF VINYLIDENE POLYFLUORIDE
BRPI0906764A2 (pt) Processos
BRPI0907376A2 (pt) Fotobiorretador
HUE044171T2 (hu) Hozzáférési mód alapú hozzáférés vezérlés
BRPI0914649A2 (pt) Piprazolo-quinazolinas
BRPI0908116A2 (pt) pulverizador
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
EP2321062A4 (en) Sprayer
BRPI0907122A2 (pt) Piridoindóis (1-azinona) substituídos
DE602008003970D1 (de) Strahlstromkalibriersystem
DK2234976T3 (da) Nye pyrazol-substituerede arylamider
BRPI0907522A2 (pt) biarlamidas
BRPI0923237A2 (pt) compostos de 4-azetidinil-1-heteroaril-ciclohexanol antagonistas de ccr2
FI20115686L (fi) Liikkeen arviointitekniikat
DE112009000183A5 (de) Sicherheitsvorreiber
BRPI0909634A2 (pt) 2-aminoquinolinas
DK2379722T3 (da) Ekspressionsvektor
DE112009001946A5 (de) Mobelauszugsführung
BRPI0913036A2 (pt) contrapeso
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
BRPI0909637A2 (pt) 2-aminoquinolinas
EP2277578A4 (en) NEBULIZER

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.